SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-027151
Filing Date
2021-02-24
Accepted
2021-02-24 07:54:28
Documents
1
Period of Report
2021-02-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217761-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm217761-2_4seq1.xml 4 3675
  Complete submission text file 0001104659-21-027151.txt   5233
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address
Lamstein Joshua R (Reporting) CIK: 0001665280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39788 | Film No.: 21668521

Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations